UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 168

Sortiert nach

Effect of Food on the Bioavailability of Omadacycline in Healthy Participants

Journal of clinical pharmacology, 2017-03, Vol.57 (3), p.321-327

2017

Volltextzugriff (PDF)

The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Abdominal Infections: Analysis of Pooled Clinical Trial Data

Clinical infectious diseases, 2005-09, Vol.41 (Supplement-5), p.S354-S367

2005

Volltextzugriff (PDF)

Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure

Circulation (New York, N.Y.), 2003-04, Vol.107 (15), p.1985-1990

2003

Volltextzugriff (PDF)

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam

Antimicrobial Agents and Chemotherapy, 2005-11, Vol.49 (11), p.4658-4666

2005

Volltextzugriff (PDF)

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

Circulation (New York, N.Y.), 2001-05, Vol.103 (18), p.2254-2259

2001

Volltextzugriff (PDF)

The prognostic importance of different definitions of worsening renal function in congestive heart failure

Journal of cardiac failure, 2002-06, Vol.8 (3), p.136-141

2002

Volltextzugriff (PDF)

Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections

Future microbiology, 2016-10, Vol.11 (11), p.1421-1434

2016

Volltextzugriff (PDF)

Omadacycline for Bacterial Infections. Reply

The New England journal of medicine, 2019-05, Vol.380 (21), p.2073-2074

2019

Volltextzugriff (PDF)

Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction

The New England journal of medicine, 1997-01, Vol.336 (4), p.251-257, Article 251

1997

Volltextzugriff (PDF)

Omadacycline for Community-Acquired Bacterial Pneumonia

The New England journal of medicine, 2019-02, Vol.380 (6), p.517-527

2019

Volltextzugriff (PDF)

Omadacycline for Acute Bacterial Skin and Skin-Structure Infections

The New England journal of medicine, 2019-02, Vol.380 (6), p.528-538

2019

Volltextzugriff (PDF)

Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure

The American journal of cardiology, 1999-06, Vol.83 (11), p.1544-1547

1999

Volltextzugriff (PDF)

Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial

The Lancet infectious diseases, 2019-10, Vol.19 (10), p.1080-1090

2019

Volltextzugriff (PDF)

Omadacycline for Bacterial Infections

The New England journal of medicine, 2019-05, Vol.380 (21), p.2072-2074

2019

Volltextzugriff (PDF)

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure

Journal of the American College of Cardiology, 2004-01, Vol.43 (1), p.61-67

2004

Volltextzugriff (PDF)

Cardiac Resynchronization in Chronic Heart Failure

The New England journal of medicine, 2002-06, Vol.346 (24), p.1845-1853

2002

Volltextzugriff (PDF)

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

The American heart journal, 2004-02, Vol.147 (2), p.331-338

2004

Volltextzugriff (PDF)

In vivo measurement of water diffusion in the human heart

Magnetic resonance in medicine, 1994-09, Vol.32 (3), p.423-428

1994

Volltextzugriff (PDF)

Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial

The American heart journal, 2003-10, Vol.146 (4), p.705-712

2003

Volltextzugriff (PDF)

Acute hemodynamic and clinical effects of levosimendan in patients with severe Heart failure

Circulation (New York, N.Y.), 2000-10, Vol.102 (18), p.2222-2227

2000

Volltextzugriff (PDF)

Cardiac Safety of Omadacycline in the IV/oral Phase 3 Acute Bacterial Skin and Skin Structure Infection (ABSSSI) and in the IV/oral Phase 3 Community-acquired Bacterial Pneumonia (CABP) Studies

Open forum infectious diseases, 2017-10, Vol.4 (suppl_1), p.S544-S545

2017

Volltextzugriff (PDF)

Successful explantation of a ventricular assist device following fulminant influenza type A-associated myocarditis

The Journal of heart and lung transplantation, 2002-02, Vol.21 (2), p.290-293

2002

Volltextzugriff (PDF)

Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial

International journal of infectious diseases, 2005-09, Vol.9 (5), p.251-261

2005

Volltextzugriff (PDF)

Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients

Clinical therapeutics, 2004-05, Vol.26 (5), p.704-714

2004

Volltextzugriff (PDF)

Effect of Nitric Oxide Synthase Inhibition on Bleeding Time in Humans

Journal of cardiovascular pharmacology, 1995-08, Vol.26 (2), p.339-339

1995

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(112)
Life Sciences & Biomedicine
(105)
Humans
(87)
Male
(62)
Female
(59)
Middle Aged
(53)
Biological And Medical Sciences
(51)
Medical Sciences
(46)
Cardiac & Cardiovascular Systems
(43)
Cardiovascular System & Cardiology
(43)
Adult
(38)
Aged
(24)
Heart
(17)
Heart Failure
(15)
Animals
(14)
Treatment Outcome
(14)
Cardiology. Vascular System
(13)
Peripheral Vascular Disease
(12)
Pharmacology. Drug Treatments
(12)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of Food on the Bioavailability of Omadacycline in Healthy Participants

The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra-Abdominal Infections: Analysis of Pooled Clinical Trial Data

Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

The prognostic importance of different definitions of worsening renal function in congestive heart failure

Omadacycline: development of a novel aminomethylcycline antibiotic for treating drug-resistant bacterial infections

Omadacycline for Bacterial Infections. Reply

Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction

Omadacycline for Community-Acquired Bacterial Pneumonia

Omadacycline for Acute Bacterial Skin and Skin-Structure Infections

Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure

Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase 3, double-blind, multicentre, randomised, controlled, non-inferiority trial

Omadacycline for Bacterial Infections

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure

Cardiac Resynchronization in Chronic Heart Failure

Relationship between heart failure treatment and development of worsening renal function among hospitalized patients

In vivo measurement of water diffusion in the human heart

Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial

Acute hemodynamic and clinical effects of levosimendan in patients with severe Heart failure

Cardiac Safety of Omadacycline in the IV/oral Phase 3 Acute Bacterial Skin and Skin Structure Infection (ABSSSI) and in the IV/oral Phase 3 Community-acquired Bacterial Pneumonia (CABP) Studies

Successful explantation of a ventricular assist device following fulminant influenza type A-associated myocarditis

Efficacy and safety of tigecycline monotherapy compared with vancomycin plus aztreonam in patients with complicated skin and skin structure infections: Results from a phase 3, randomized, double-blind trial

Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients

Effect of Nitric Oxide Synthase Inhibition on Bleeding Time in Humans

Suchergebnisse filtern